Cellular and molecular studies on infant null acute lymphoblastic leukemia

Area of Science:

• Pediatric Oncology
• Hematology
• Molecular Biology

Background:

• Infant null acute lymphoblastic leukemia (ALL) is a rare and aggressive form of childhood cancer.
• Understanding the cellular and molecular underpinnings of infant ALL is crucial for developing targeted therapies.

Purpose of the Study:

• To investigate the cellular and molecular characteristics of eight infant null ALL cases.
• To identify common features and potential precursor cell origins in infant null ALL.

Main Methods:

• Flow cytometry for immunophenotyping (CD10, HLA-DR, CD19, CD33, CD15).
• Electron microscopy and cell culture to assess myeloid features.
• Cytogenetic analysis for chromosomal abnormalities (11q23 breaks).
• Molecular analysis of immunoglobulin and T cell receptor gene rearrangements, and c-ets 1 oncogene status.

Main Results:

• All patients presented with high leukocyte counts and organomegaly; two had CNS infiltration.
• Immunophenotyping revealed a null ALL pattern (CD10-, HLA-DR+, CD19+), with two cases coexpressing myeloid markers (CD33, CD15).
• Cytogenetic analysis identified a common 11q23 break in 7 of 8 cases.
• Molecular analysis showed immunoglobulin heavy-chain gene rearrangement in all cases, but no T cell receptor gene rearrangement.

Conclusions:

• Infant null ALL exhibits heterogeneity, with some cases displaying mixed lymphoid and myeloid features.
• The consistent 11q23 chromosomal abnormality and immunoglobulin gene rearrangement suggest a common origin from a precursor cell with both B and myeloid progenitor characteristics.
• These findings contribute to understanding the pathogenesis of infant ALL and may inform future therapeutic strategies.